Literature DB >> 2170558

Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.

M Zaidi1, H K Datta, B S Moonga, I MacIntyre.   

Abstract

Calcitonin inhibits osteoclastic bone resorption and its action involves two separate acute effects on the osteoclast, both essential to the action of the hormone: abolition of cell motility (Q) and marked cellular retraction (R). The former was mimicked by dibutyryl cyclic AMP and cholera toxin and the latter by pertussis toxin, ionomycin and increases in ambient calcium. Aluminium fluoride ions produced both Q and R effects, while lithium prevented both. In addition, calcitonin elicited a biphasic elevation of cytosolic-free calcium in single isolated osteoclasts. We propose that the action of calcitonin is mediated by at least two G proteins, one responsible for the Q effect and the other for the R effect. In addition, two second messengers, cyclic AMP and calcium, are involved. These findings may help to explain the potency of calcitonin in inhibiting bone resorption, and may allow the rational design of new therapeutic agents designed to alter osteoclast behaviour.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170558     DOI: 10.1677/joe.0.1260473

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  19 in total

1.  Calcitonin and bone formation: a knockout full of surprises.

Authors:  Mone Zaidi; Baljit S Moonga; Etsuko Abe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function.

Authors:  M Zaidi; A S Alam; V S Shankar; B E Bax; B S Moonga; P J Bevis; M Pazianas; C L Huang
Journal:  Eur Biophys J       Date:  1992       Impact factor: 1.733

3.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Authors:  Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Journal:  Mol Endocrinol       Date:  2005-04-28

4.  Calpain is required for normal osteoclast function and is down-regulated by calcitonin.

Authors:  Marilena Marzia; Riccardo Chiusaroli; Lynn Neff; Na-Young Kim; Athar H Chishti; Roland Baron; William C Horne
Journal:  J Biol Chem       Date:  2006-02-03       Impact factor: 5.157

5.  Tamoxifen stimulates calcitonin-producing thyroid C-cells and prevents trabecular bone loss in a rat model of androgen deficiency.

Authors:  Branko Filipović; Branka Šošić-Jurjević; Vladimir Ajdžanović; Jasmina Živanović; Esma Isenović; Florina Popovska-Perčinić; Verica Milošević
Journal:  J Anat       Date:  2015-04-07       Impact factor: 2.610

6.  Carbonic anhydrase II gene transcript in cultured osteoclasts from neonatal rats: effect of calcitonin.

Authors:  M H Zheng; Y Fan; S Wysocki; D J Wood; J M Papadimitriou
Journal:  Cell Tissue Res       Date:  1994-04       Impact factor: 5.249

7.  Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

Authors:  I MacIntyre; M Zaidi; A S Alam; H K Datta; B S Moonga; P S Lidbury; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.

Authors:  A H Gorn; H Y Lin; M Yamin; P E Auron; M R Flannery; D R Tapp; C A Manning; H F Lodish; S M Krane; S R Goldring
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Daidzein administration positively affects thyroid C cells and bone structure in orchidectomized middle-aged rats.

Authors:  B Filipović; B Sosić-Jurjević; V Ajdzanović; D Brkić; M Manojlović-Stojanoski; V Milosević; M Sekulić
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

10.  SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.

Authors:  Lesley J Murray; Tinya J Abrams; Kelly R Long; Theresa J Ngai; Lisa M Olson; Weiru Hong; Paul K Keast; Jacqueline A Brassard; Anne Marie O'Farrell; Julie M Cherrington; Nancy K Pryer
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.